Table 3.
Quality of evidence assessment for each outcome
| Quality assessment | Summary of findings | |||||||
| Outcome | Limitations | Inconsistency | Indirectness | Imprecision | Publication bias | Total number of participants | Conclusion | Quality of evidence (GRADE) |
| Rest pain score at 2 postoperative hours (analogue scale, 0–10) | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1115 | No difference between groups | Moderate quality (⊕⊕⊕O)e |
| Rest pain score at 24 postoperative hours (analogue scale, 0–10) | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1636 | Reduced rest pain score in liposomal bupivacaine group | Moderate quality (⊕⊕⊕O)e |
| Rest pain score at 48 postoperative hours (analogue scale, 0–10) | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1759 | Reduced rest pain score in liposomal bupivacaine group | Moderate quality (⊕⊕⊕O)e |
| Rest pain score at 72 postoperative hours (analogue scale, 0–10) | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1570 | Reduced rest pain score in liposomal bupivacaine group | Moderate quality (⊕⊕⊕O)e |
| Interval iv morphine equivalent consumption at 0–24 postoperative hours | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1414 | No difference between groups | Moderate quality (⊕⊕⊕O)e |
| Interval iv morphine equivalent consumption at 24–48 postoperative hours | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1153 | No difference between groups | Moderate quality (⊕⊕⊕O)e |
| Interval iv morphine equivalent consumption at 48–72 postoperative hours | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1067 | No difference between groups | Moderate quality (⊕⊕⊕O)e |
| Presence of nausea or vomiting at 24 postoperative hours | No major limitationsa | No serious inconsistency | No serious indirectnessc | No serious imprecisiond | No publication bias | 141 | No difference between groups | Moderate quality (⊕⊕⊕O)f |
| Presence of nausea or vomiting at 48 postoperative hours | No major limitationsa | No serious inconsistency | No serious indirectnessc | No serious imprecisiond | No publication bias | 141 | No difference between groups | Moderate quality (⊕⊕⊕O)f |
| Presence of nausea or vomiting at 72 postoperative hours | No major limitationsa | No serious inconsistency | No serious indirectnessc | No serious imprecisiond | No publication bias | 314 | Presence of nausea or vomiting reduced in liposomal bupivacaine group | Moderate quality (⊕⊕⊕O)f |
| Hospital length of stay (hours) | No major limitationsa | Serious inconsistencyb | No serious indirectnessc | No serious imprecisiond | No publication bias | 1381 | No difference between groups | Moderate quality (⊕⊕⊕O)e |
As only a limited number of studies suffered from a high-risk of bias, we estimated there is no major limitation.
I2 above 50%.
Consistent definition of the reported outcome.
No serious imprecision as the clinical decision would not be modified whether the upper of lower boundary limit of the confidence interval represented the truth.
We rated down the quality of evidence for serious inconsistency.
We rated down for limitations, as six trials or less reported this outcome.